Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 125 | 132 | +7 |
| Shares | 30.1M | 31.8M | +1.67M (+5.5%) |
| Value | $450.0M | $339.6M | −$110.4M (−24.5%) |
New holders (23)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (16)
Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Hillsdale Investment Management Inc. | 244,017 | $3.66M |
| EAM Global Investors LLC | 116,864 | $1.75M |
| Cubist Systematic Strategies, LLC | 110,620 | $1.66M |
| EAM Investors, LLC | 79,046 | $1.18M |
| Caxton Associates LP | 66,055 | $989.5K |
| Victory Capital Management Inc | 65,900 | $987.2K |
| Walleye Capital LLC | 48,217 | $722.3K |
| HRT Financial LP | 39,751 | $595.0K |
| Y-Intercept (Hong Kong) Ltd | 12,920 | $193.5K |
| Rockefeller Capital Management L.P. | 5,750 | $86.0K |
| Quantbot Technologies LP | 5,604 | $83.9K |
| Lazard Asset Management LLC | 4,648 | $69.0K |
| Altshuler Shaham Ltd | 3,956 | $59.3K |
| Balyasny Asset Management LLC | 2,695 | $40.4K |
| Metropolitan Life Insurance Co | 1,846 | $27.7K |
| Quadrant Capital Group LLC | 585 | $8.76K |